Periostin-An inducer of pro-fibrotic phenotype in monocytes and monocyte-derived macrophages in systemic sclerosis

PLoS One. 2023 Aug 2;18(8):e0281881. doi: 10.1371/journal.pone.0281881. eCollection 2023.

Abstract

Enhanced circulating blood periostin levels positively correlate with disease severity in patients with systemic sclerosis (SSc). Monocytes/macrophages are predominantly associated with the pathogenesis of SSc, but the effect of periostin on immune cells, particularly monocytes and macrophages, still remains to be elucidated. We examined the effect of periostin on monocytes and monocyte-derived macrophages (MDM) in the pathogenesis of SSc. The modified Rodnan total skin thickness score in patients with dcSSc was positively correlated with the proportion of CD80-CD206+ M2 cells. The proportion of M2 macrophages was significantly reduced in rPn-stimulated MDMs of HCs compared to that of SSc patients. The mRNA expression of pro-fibrotic cytokines, chemokines, and ECM proteins was significantly upregulated in rPn-stimulated monocytes and MDMs as compared to that of control monocytes and MDMs. A similar trend was observed for protein expression in the respective MDMs. In addition, the ratio of migrated cells was significantly higher in rPn-stimulated as compared to control monocytes. These results suggest that periostin promotes inflammation and fibrosis in the pathogenesis of SSc by possible modulation of monocytes/macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fibrosis
  • Humans
  • Macrophages / metabolism
  • Monocytes* / metabolism
  • Phenotype
  • Scleroderma, Systemic* / pathology

Substances

  • POSTN protein, human

Grants and funding

Yukie Yamaguchi Grant No. 20K08656 This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research NO.